Screening and Monitoring Before and During Systemic Therapy: Recommendations for Patients With Psoriasis.
When patients with psoriasis are candidates for systemic therapy, the list of appropriate agents for each patient should be derived from careful patient and family history and selected laboratory screening protocols so that the potential risks associated with treatment can be minimized. Once a therapeutic choice is made, monitoring strategies also are necessary for early identification and intervention of adverse events that may arise. In addition to appropriate screening and monitoring protocols, communication between patient and clinician is essential to enhance the benefits of therapy and minimize the risks. Semin Cutan Med Surg 34(supp2):S40-S42 © 2015 published by Frontline Medical Communications.